Group items tagged

Roche is pleased to announce that we are accepting applications for the 2013 TCRC Young Investigators Award.  The awards are intended to provide support for the earlier stages of scientific research career development, so they are to be awarded to the employing institutions of promising emerging researchers.  Proposals will be evaluated based on scientific merit and innovation of the projects proposed to be conducted using the awards.   Four awards will be presented on Oct 1, 2013 during the scientific symposium inaugurating Roche's Translational and Clinical Research Center in New York City.   Researchers performing investigations (clinical, in vitro/in vivo or informatics) focused on disease understanding of the following disease areas are encouraged to apply: Cardiovascular & Metabolism - Diabetes and related complications   Neuroscience - Spinal Muscular Atrophy Virology - Influenza Oncology - Treatment and diagnosis of Acute Myeloid Leukemia (AML).

The purpose of this Funding Opportunity Announcement (FOA) is to encourage projects to generate fundamental knowledge of affective processes. Basic affective science projects should have key downstream consequences for single (e.g., genetic testing consent) and multiple (e.g., adherence to oral chemotherapy regimen) event decisions and behaviors across the cancer prevention and control continuum. The FOA is expected to encourage scientific disciplines that have not traditionally conducted cancer research such as affective and cognitive neuroscience, decision science, and consumer science to elucidate perplexing and understudied problems in basic affective and decision sciences with promise of having downstream implications for cancer prevention and control science.

This Funding Opportunity Announcement (FOA) is issued by the National Institute of Neurological Disorders and Stroke (NINDS) in conjunction with the NIH Pain Consortium. It solicits R21 grant applications from institutions/organizations to perform innovative research that will elucidate the mechanisms underlying migraine, expand our current knowledge of the role of genetic, physiological, biopsychosocial, and environmental influences in migraine susceptibility and progression, and explore new therapeutic targets and therapies for acute migraine management and longer term prevention.

This Funding Opportunity Announcement (FOA) is issued by the National Institute of Neurological Disorders and Stroke (NINDS) in conjunction with the NIH Pain Consortium. It solicits R01 grant applications from institutions/organizations to perform innovative research that will elucidate the mechanisms underlying migraine, expand our current knowledge of the role of genetic, physiological, biopsychosocial, and environmental influences in migraine susceptibility and progression, and explore new therapeutic targets and therapies for acute migraine management and longer term prevention.

This funding opportunity announcement (FOA) solicits R01 grant applications from applicant organizations that propose to develop and implement interventions to remediate age-related cognitive decline. A crucial feature of these applications will be the embedding of the testing of the proposed intervention into a measurement framework that will: 1) help elucidate its mechanism of action; 2) identify specific individuals who are more likely or less likely to benefit from the intervention, and 3) examine whether adaptive plastic changes have occurred in the structure or function of the CNS as a result of the intervention, and whether these neural changes help explain the pattern of improvement seen in cognitive functioning. Although projects may include an observational component, the interventions developed should be tested in a randomized clinical trial (RCT).

This Funding Opportunity Announcement (FOA) is intended to stimulate model-driven research to understand the ways that people make decisions about engaging in behaviors that impact the risk of acquiring or transmitting HIV, or to adhere to treatments for HIV. Decision making processes may contribute to both substance use/abuse and other HIV acquisition or transmission risks. A better understanding of decision making processes in the context of brain neural networks and their associated functions would lead to the development of better strategies to reduce the frequency of HIV-risk behaviors. Therefore, this FOA encourages applications to study 1) cognitive, motivational or emotional mechanisms and/or 2) brain neuroendocrine and reinforcement systems that related to HIV-risk behaviors or treatment non-compliance. Interdisciplinary studies that incorporate approaches from psychology, economics, anthropology, sociology, decision sciences, neuroscience and computational modeling are encouraged. This FOA for R01 applications solicits empirical, hypothesis-driven, confirmatory research and modeling approaches. Exploratory, descriptive or hypothesis-generating research are more appropriate for the complementary FOAs using the R21 or R03 mechanisms. In no cases, should research involving animals be proposed.

This Funding Opportunity Announcement (FOA) is intended to stimulate model-driven research to understand the ways that people make decisions about engaging in behaviors that impact the risk of acquiring or transmitting HIV, or to adhere to treatments for HIV. Decision making processes may contribute to both substance use/abuse and other HIV acquisition or transmission risks. A better understanding of decision making processes in the context of brain neural networks and their associated functions would lead to the development of better strategies to reduce the frequency of HIV-risk behaviors. Therefore, this FOA encourages applications to study 1) cognitive, motivational or emotional mechanisms and/or 2) brain neuroendocrine and reinforcement systems that related to HIV-risk behaviors or treatment non-compliance. Interdisciplinary studies that incorporate approaches from psychology, economics, anthropology, sociology, decision sciences, neuroscience and computational modeling are encouraged. This FOA for R21 applications is intended to encourage exploratory and developmental research projects by providing support for the early and conceptual stages of these projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact.

This Funding Opportunity Announcement (FOA) is intended to stimulate model-driven research to understand the ways that people make decisions about engaging in behaviors that impact the risk of acquiring or transmitting HIV, or to adhere to treatments for HIV. Decision making processes may contribute to both substance use/abuse and other HIV acquisition or transmission risks. A better understanding of decision making processes in the context of brain neural networks and their associated functions would lead to the development of better strategies to reduce the frequency of HIV-risk behaviors. Therefore, this FOA encourages applications to study 1) cognitive, motivational or emotional mechanisms and/or 2) brain neuroendocrine and reinforcement systems that related to HIV-risk behaviors or treatment non-compliance. Interdisciplinary studies that incorporate approaches from psychology, economics, anthropology, sociology, decision sciences, neuroscience and computational modeling are encouraged. This FOA for R03 applications encourages small research projects that can be carried out in a short period of time with limited resources. The R03 activity code supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. In no cases, should research involving animals be proposed.

The purpose of this Funding Opportunity Announcement (FOA) is to encourage the submission of grant applications that propose to examine the molecular, cellular, circuit, and behavioral responses to neuroimmune signaling within the central nervous system (CNS) as it pertains to the initiation, escalation, and maintenance of, and the neurological consequences resulting from, substance use disorders (SUDs), and to abstinence and withdrawal from, and subsequent relapse of, drug use. The goal of this understudied area of research is to determine the extent to which neuroimmune responses contribute to or protect against current and future risk and consequences of SUDs.

The purpose of this Funding Opportunity Announcement (FOA) is to encourage the submission of research project grant applications that propose to examine the molecular, cellular, circuit, and behavioral responses to neuroimmune signaling within the central nervous system (CNS) as it pertains to the initiation, escalation, and maintenance of, and the neurological consequences resulting from, substance use disorders (SUDs), and to abstinence and withdrawal from, and subsequent relapse of, drug use. The goal of this understudied area of research is to determine the extent to which neuroimmune responses contribute to or protect against current and future risk and consequences of SUDs.

The Society for Women's Health Research (SWHR) is pleased to announce a travel award opportunity for neuroscience students to present their research on sex differences in the brain at a scientific conference in 2014. SWHR is accepting applications for travel awards sponsored by Donald G. and Darel Stein in memory of Anne Hammer. Awardees must provide evidence that the poster or oral presentation has been accepted for inclusion in the conference. Funds can be used to pay for expenses associated with attending a neuroscience-related conference, including an abstract submission fee, society membership and/or conference registration, and travel and/or lodging. The research presented must stem from a current project on sex differences in neuroscience.

This Funding Opportunity Announcement (FOA) encourages Exploratory/Developmental Research Project Grant (R21) applications from institutions/organizations that propose to study the neuroimmune mechanisms of alcohol related disorders. Studies using animal models and post-mortem human alcoholic brains suggest that alcohol exposure alters the neuroimmune system in the brain. However, it remains unclear how the altered neuroimmune signaling contributes to brain functional and behavioral changes associated with alcohol dependence. Recent studies reveal that neuroimmune molecules are expressed in neurons and glia, and play an important role in modulating synaptic function, neurodevelopment, and neuroendocrine function. These neuromodulatory properties, together with their essential roles in neuroinflammation, provide a new frame work to understand the role of neuroimmune factors in mediating neuroadaptation and behavioral phenotypes associated with alcohol use disorders. Studies supported by this FOA will provide fundamental insights of neuroimmune mechanisms underlying brain functional and behavioral changes induced by alcohol.

This Funding Opportunity Announcement (FOA) encourages Exploratory/Developmental Research Project Grant (R21) applications from institutions/organizations that propose to study the neuroimmune mechanisms of alcohol related disorders. Studies using animal models and post-mortem human alcoholic brains suggest that alcohol exposure alters the neuroimmune system in the brain. However, it remains unclear how the altered neuroimmune signaling contributes to brain functional and behavioral changes associated with alcohol dependence. Recent studies reveal that neuroimmune molecules are expressed in neurons and glia, and play an important role in modulating synaptic function, neurodevelopment, and neuroendocrine function. These neuromodulatory properties, together with their essential roles in neuroinflammation, provide a new frame work to understand the role of neuroimmune factors in mediating neuroadaptation and behavioral phenotypes associated with alcohol use disorders. Studies supported by this FOA will provide fundamental insights of neuroimmune mechanisms underlying brain functional and behavioral changes induced by alcohol.

This Funding Opportunity Announcement (FOA) invites applications for Silvio O. Conte Centers for Basic or Translational Mental Health Research. The institute seeks teams of researchers working at different levels of analysis and employing integrative, novel, and creative experimental approaches to address high-risk, high-impact questions with the primary objective of: (a) advancing the state of the science in brain and behavior research that will ultimately provide the foundation for understanding mental disorders; (b) supporting the integration and translation of basic and clinical neuroscience research on severe mental illnesses; and/or (c) advancing our understanding of the neurobehavioral developmental mechanisms and trajectories of psychopathology that begin in childhood and adolescence. The Conte Centers program is intended to support interdisciplinary basic and/or translational research demonstrating an extraordinary level of synergy, integration, and potential for advancing the state of the field. This program is intended only for projects that could not be achieved using other, more standard grant mechanisms. The Conte Centers program also provides an opportunity to establish interdisciplinary basic and/or translational research experiences for individuals in training.

This Funding Opportunity Announcement (FOA) invites research grant applications from organizations/institutions that propose the development of novel radioligands for positron emission tomography (PET) or single photon emission computed tomography (SPECT) imaging in human brain, and that incorporate pilot or clinical feasibility evaluation in pre-clinical studies, model development, or clinical studies.

This funding opportunity announcement (FOA) is issued by the National Institute of Neurological Disorders and Stroke to enable submission of program project grant applications that propose to conduct innovative, interactive research to answer significant scientific questions that are important for the mission of NINDS, via a synergistic collaboration between outstanding scientists who might not otherwise collaborate. The program project grant is designed to support research in which the funding of several interdependent highly meritorious projects as a group offers significant scientific advantages over support of these same projects as individual research grants.

Lumosity invites researchers to submit proposals for studies that use functional neuroimaging techniques to investigate mechanisms underlying cognitive processes implicated in Lumosity's games and assessments. These studies would ideally involve both neuroimaging and behavioral methods with healthy adult populations. Examples of types of projects that would be prioritized include, but are not limited to, demonstrations of: Task-related neural activity within and across brain regions Changes in neural activity that accompany training-related changes in cognitive performance Neural specificity of cognitive training effects All applications are encouraged to focus explicitly on the use of neuroimaging as a tool for studying Lumosity's cognitive training platform. 

This funding opportunity announcement (FOA) spans across the missions of several NIH Institutes and Centers (ICs) and Offices, and includes basic neuroscience and basic behavioral research, clinical and translational studies, intervention development at the individual, family and community level, efficacy trials of interventions based on evidence from basic and translational studies, and research to identify the best ways to disseminate and implement efficacious and evidence-based interventions in real-world settings. While this FOA covers all of the areas mentioned above, particular consideration will be given to applications that propose studies of the intersection that focus on the various types of violence (homicide, suicide, youth and gang-related, intimate partner) and firearms.

This funding opportunity announcement (FOA) spans across the missions of several NIH Institutes and Centers (ICs) and Offices, and includes basic neuroscience and basic behavioral research, clinical and translational studies, intervention development at the individual, family and community level, efficacy trials of interventions based on evidence from basic and translational studies, and research to identify the best ways to disseminate and implement efficacious and evidence-based interventions in real-world settings. While this FOA covers all of the areas mentioned above, particular consideration will be given to applications that propose studies of the intersection that focus on the various types of violence (homicide, suicide, youth and gang-related, intimate partner) and firearms.

This funding opportunity announcement (FOA) spans across the missions of several NIH Institutes and Centers (ICs) and Offices, and includes basic neuroscience and basic behavioral research, clinical and translational studies, intervention development at the individual, family and community level, efficacy trials of interventions based on evidence from basic and translational studies, and research to identify the best ways to disseminate and implement efficacious and evidence-based interventions in real-world settings. While this FOA covers all of the areas mentioned above, particular consideration will be given to applications that propose studies of the intersection that focus on the various types of violence (homicide, suicide, youth and gang-related, intimate partner) and firearms.